| Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions JA Coppinger, G Cagney, S Toomey, T Kislinger, O Belton, ... Blood 103 (6), 2096-2104, 2004 | 997 | 2004 |
| Antidiabetic effects of cis-9, trans-11–conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue F Moloney, S Toomey, E Noone, A Nugent, B Allan, CE Loscher, ... Diabetes 56 (3), 574-582, 2007 | 225 | 2007 |
| The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA E Oliver, F McGillicuddy, C Phillips, S Toomey, HM Roche Proceedings of the Nutrition Society 69 (2), 232-243, 2010 | 170 | 2010 |
| Profound resolution of early atherosclerosis with conjugated linoleic acid S Toomey, B Harhen, HM Roche, D Fitzgerald, O Belton Atherosclerosis 187 (1), 40-49, 2006 | 155 | 2006 |
| Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis OA Belton, A Duffy, S Toomey, DJ Fitzgerald Circulation 108 (24), 3017-3023, 2003 | 154 | 2003 |
| Regression of pre-established atherosclerosis in the apoE−/− mouse by conjugated linoleic acid S Toomey, H Roche, D Fitzgerald, O Belton Biochemical Society Transactions 31 (5), 1075-1079, 2003 | 115 | 2003 |
| HER2-family signalling mechanisms, clinical implications and targeting in breast cancer N Elster, DM Collins, S Toomey, J Crown, AJ Eustace, BT Hennessy Breast cancer research and treatment 149, 5-15, 2015 | 91 | 2015 |
| Use of exhaled breath condensate (EBC) in the diagnosis of SARS-COV-2 (COVID-19) DJ Ryan, S Toomey, SF Madden, M Casey, OS Breathnach, PG Morris, ... Thorax 76 (1), 86-88, 2021 | 64 | 2021 |
| Immune effects of bevacizumab: killing two birds with one stone YY Elamin, S Rafee, S Toomey, BT Hennessy Cancer Microenvironment 8, 15-21, 2015 | 63 | 2015 |
| Attenuation of inflammation and cellular stress‐related pathways maintains insulin sensitivity in obese type I interleukin‐1 receptor knockout mice on a high‐fat diet B de Roos, V Rungapamestry, K Ross, G Rucklidge, M Reid, G Duncan, ... Proteomics 9 (12), 3244-3256, 2009 | 60 | 2009 |
| BCL-2 system analysis identifies high-risk colorectal cancer patients AU Lindner, M Salvucci, C Morgan, N Monsefi, AJ Resler, M Cremona, ... Gut 66 (12), 2141-2148, 2017 | 51 | 2017 |
| A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies … N Elster, M Cremona, C Morgan, S Toomey, A Carr, A O’Grady, ... Breast cancer research and treatment 149, 373-383, 2015 | 50 | 2015 |
| Conjugated linoleic acid: a functional nutrient in the different pathophysiological components of the metabolic syndrome? S Toomey, J McMonagle, HM Roche Current Opinion in Clinical Nutrition & Metabolic Care 9 (6), 740-747, 2006 | 47 | 2006 |
| Effects of HER family–targeting tyrosine kinase inhibitors on antibody-dependent cell-mediated cytotoxicity in HER2-expressing breast cancer DM Collins, SF Madden, N Gaynor, D AlSultan, M Le Gal, AJ Eustace, ... Clinical Cancer Research 27 (3), 807-818, 2021 | 44 | 2021 |
| Transcriptomic coordination in the human metabolic network reveals links between n-3 fat intake, adipose tissue gene expression and metabolic health MJ Morine, AC Tierney, B Van Ommen, H Daniel, S Toomey, IMF Gjelstad, ... PLoS computational biology 7 (11), e1002223, 2011 | 43 | 2011 |
| Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted … S Toomey, AJ Eustace, J Fay, KM Sheehan, A Carr, M Milewska, ... Breast Cancer Research 19, 1-12, 2017 | 40 | 2017 |
| Preclinical evaluation of a novel triple-acting PIM/PI3K/mTOR inhibitor, IBL-302, in breast cancer SP Kennedy, M O’Neill, D Cunningham, PG Morris, S Toomey, ... Oncogene 39 (14), 3028-3040, 2020 | 28 | 2020 |
| Brief report on the detection of the EGFR T790M mutation in exhaled breath condensate from lung cancer patients RJ Smyth, SM Toomey, A Sartori, E O'Hanrahan, SD Cuffe, ... Journal of Thoracic Oncology 13 (8), 1213-1216, 2018 | 27 | 2018 |
| Inter‐organ proteomic analysis reveals insights into the molecular mechanisms underlying the anti‐diabetic effects of cis‐9, trans‐11‐conjugated linoleic acid in ob/ob mice V Rungapamestry, J McMonagle, C Reynolds, G Rucklidge, M Reid, ... Proteomics 12 (3), 461-476, 2012 | 26 | 2012 |
| A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib J O’Shea, M Cremona, C Morgan, M Milewska, F Holmes, V Espina, ... Oncotarget 8 (49), 85120, 2017 | 25 | 2017 |
